News

For interview requests or speaking opportunities, get in touch with our Communications team.

Press
Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
by Quotient Therapeutics
03/24/2026
Press
Quotient Therapeutics Appoints Seasoned Life Sciences Executive, Susan Keefe, as Chief Financial Officer
by Quotient Therapeutics
02/02/2026
Press
Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK
by Quotient Therapeutics
11/20/2025
Press
Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer
by Quotient Therapeutics
09/29/2025
Press
Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics
by Quotient Therapeutics
04/29/2025
Media
Doctors Thought They Knew What a Genetic Disease Is. They Were Wrong.
The Atlantic
01/02/2025
Press
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
by Quotient Therapeutics
11/07/2024
Media
Europe’s rising biotech stars: 10 startups to watch in 2024
Labiotech
09/26/2024
Press
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
by Quotient Therapeutics
08/28/2024
Press
Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer
by Quotient Therapeutics
08/07/2024
Media
The potential of somatic genomics in drug discovery and development with Jake Rubens
The Genetics Podcast
04/18/2024
Media
Here, There, and Everywhere: Somatic Genomics Uncovers DNA Variants to Inspire Drug Discovery
GEN Biotechnology
04/18/2024
Press
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
by Quotient Therapeutics
11/21/2023
Media
Flagship launches first UK biotech Quotient with genome sequencing platform
Fierce Biotech
11/21/2023
Media
US $50m helps Sanger-inspired startup to create transformative medicine suite
Business Weekly
11/21/2023
Media
From somatic mutations to Quotient
Sanger Institute
11/21/2023